Skip to main content
. 2017 Sep 27;97(3 Suppl):76–88. doi: 10.4269/ajtmh.17-0203

Figure 4.

Figure 4.

Proportion of women receiving sulfadoxine-pyrimethamine (SP) for prevention of malaria in pregnancy, Malawi, 2000–2010. Estimates are shown for women (15–49 years) with a live birth in the last 2 years who took one or two doses of SP for malaria prevention during their last pregnancy, regardless of the source of the medication.